Previous studies have suggested elevated PRL in COVID-19 cases compared to non-infected patients; however, study heterogeneity is noted, leading authors to conclude that infection-related stress and not COVID-19 per se is possibly what primarily drives hyperprolactinemia [4,28,29,30]. The gene discussed is PRL; the disease is COVID-19.